MedTech Integrates 2021 Track 1
DETECTION
Disease detection is key to diagnosis and treatment. How are we accelerating the clinical translation of MedTech, and is it impacting wealth as well as health?
Welcome and opening remarks
Martino Picardo, Chairman, Discovery Park
An interview with Darren Curry
Interview conducted by Paul Wicks, Independent Consultant, Wicks Digital Health
An interview with Simon Donovan
Interview conducted by Martino Picardo, Chairman, Discovery Park
Listen to your heart
Predicting, diagnosing and monitoring cardiac conditions using health tech and wearables.
FACILITATED BY
MIKE HANNAY | Managing Director | Medical Technologies Innovation Facility
PANELLISTS INCLUDE
CHRIS MORTON | Chief Executive Officer | ELEM Biotech
DANIEL YAZDI | Medical Director | Bodyport
NICK CLARKE | Principal Advisor | Eastern Academic Health Science Network
FOZIA AHMED | Consultant Cardiologist | Manchester University NHS Foundation Trust
HTA playbook 2.0
How will changes in processes and methods of health technology assessment impact on an already essential step in the market access journey ?
FACILITATED BY
MARK CAMPBELL | Independent Healthtech Consultant
PANELLISTS INCLUDE
MICHELLE GREEN | Project Director | York Health Economics Consortium (YHEC)
ANDREW DAVIES |Digital Health Lead | ABHI
SYLVAIN PIQUET | Co-founder | Sharp Therapeutics
CHRIS CHESTERS | Senior HTA Adviser | NICE
Health and wealth
How has the uptake of technology eased the human and financial burden on the healthcare system?
FACILITATED BY
HANNAH DAVIES| Head of External and Public Affairs| Northern Health Science Alliance
PANELLISTS INCLUDE
JANEZ BENSA | Chief Executive Officer| Parsek
HARPREET SOOD | Global Digital Health Advisor and Non-executive Director | eRB and Health Education England
ANDREW THELWELL | Chief Commercial Officer | Sky Medical Technology
DAVID BRETTLE | Chief Scientific Officer | Leeds Teaching Hospitals NHS Trust
Lost in translation
What is preventing the clinical adoption of med and health tech? How can we develop technologies to ensure they translate into clinical practice?
FACILITATED BY
NEIL EBENEZER| Medical Technologist Specialist | Department for International Trade
PANELLISTS INCLUDE
LIZ ASHALL-PAYNE | Founding Chief Executive Officer | ORCHA
RACHEL NEAMAN | Technology Leader, Non-Executive Director, Leadership Mentor and Coach | Neaman Consulting
LORNA GREEN | Director of Enterprise & Growth | Innovation Agency
ALAN SUMNER |Head of Public Affairs and Market Access | Roche Diagnostics UK & Ireland
ALISTAIR (ALLY) LONGMUIR | Medical Technology & IVD Strategy Advisor | CPI
Surgery 4.0
The future transformation in surgical care will be driven by data and information. The key elements on the path toward evidence-based surgery are new tools to measure, model, and quantify surgical processes including intraoperative decision-making and knowledge extraction. How will digital technologies impact on surgical procedures and in the operating theatre over the next decade?
FACILITATED BY
CERI WILLIAMS | Director of Research and Innovation Development | University of Leeds
PANELLISTS INCLUDE
MARK SLACK | Co-Founder and Chief Medical Officer | CMR Surgical
DANIEL LEFF | Reader in Breast Surgery and Consultant Oncoplastic Breast Surgeon | Imperial College London
MALCOLM BROWN | Medical Lead | AMRC with Boeing, University of Sheffield
JAN-PHILIPP MOHR | Founder & Chief Executive Officer | Darvis
Closing Remarks with Darren Clarke
Chief Executive, Medilink Midlands